Nuclera

Investor: Jonathan Milner, GK Goh, Elevage Medical Technologies, British Business Bank

Investor: Michael D. McCreary, Verve Ventures, M&G Catalyst, Uni Power Group, Elevage Medical Technologies, E Ink Holdings, Cambridge Innovation Capital, GK Goh, Patient Square Capital, Jonathan Milner

Investor: Innovate UK

Investor: Elevage Medical Technologies

Nuclera, a health tech company based in Cambridge, has successfully closed an £8.9 million Series C extension funding round.Summary of transaction details:Value: £8.9 millionSector: Health techAdvisor: Not disclosedKey Entities: Nuclera (Target), Elevage Medical Technologies, Jonathan Milner, British Business Bank, GK Goh (Investors)Location: Cambridge, UKNote: This funding round represents a significant boost for Nuclera's ongoing development in multiplex protein screening, reflecting strong investor interest in innovative health technologies and their market potential.

Investor: Verve Ventures, Jonathan Milner

Investor: M&G Investments, British Business Bank Future Fund, Future Planet Capital, Amadeus Capital Partners, RT Partners, E Ink, G. K. Goh